QuidelOrtho

Traded on the St. Petersburg Stock Exchange
QuidelOrtho is an American pharmaceutical company founded in 1979. It is headquartered in San Diego, California. It is the largest developer and manufacturer of diagnostic equipment that is used all over the world.
QuidelOrtho stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

QuidelOrtho balance sheet

Report period2018 2019 2020 2021 2022 2023
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

QuidelOrtho cash flows

Report period2018 2019 2020 2021 2022 2023
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

QuidelOrtho multipliers

Report period2018 2019 2020 2021 2022 2023
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

QuidelOrtho profitability

Report period2018 2019 2020 2021 2022 2023
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
QuidelOrtho assets
QuidelOrtho cash flows

QuidelOrtho shares

TickerNameTypeNominal valueISINPrice
QDEL:USQuidelOrthoCommon share-US74838J1016$36.18
QuidelOrtho news
02.11.2023
QuidelOrtho's GAAP loss for 9 months of 2023 was $17.1 million, compared to a profit of $518.4 million in the prior year. Revenue declined 4.2% to $2.3 billion versus $2.4 billion a year earlier.
04.05.2023
QuidelOrtho's GAAP net income for 3 months of 2023 was $48.8 million, down 10 times from $479.9 million in the previous year. Revenue declined 15.6% to $0.846 billion from $1.002 billion a year earlier.
16.02.2023
QuidelOrtho's GAAP net income for 2022 was $548.7 million, down 22.1% from $704.2 million in the previous year. Revenues increased 92.2% to $3.266 billion from $1.699 billion a year earlier.
03.11.2022
QuidelOrtho's GAAP net income for 9 months of 2022 was $518.4 million, up 25.6% from $412.9 million in the previous year. Revenue increased 2.3 times to $2.399 billion from $1.061 billion a year earlier.
General information
Company nameQuidelOrtho
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Life Sciences Tools & Services / Life Sciences Tools & Services
Business address12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8585521100
Mailing address12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Websitewww.quidel.com
Information disclosurewww.sec.gov